Vanda Pharmaceuticals Inc. today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA)

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing

Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles) technology

GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, has entered into a strategic research collaboration

Xcell Biosciences Australia Pty Ltd (Xcellbio), an Australian affiliate of the San Francisco-based instrumentation company focused on cell and gene therapy applications

Primrose Bio, Inc. a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApols™ ExTend

Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs

SineuGene Therapeutics Co., Ltd. a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics

Actinium Pharmaceuticals, Inc. a pioneer in the development of targeted radiotherapies, today announced it has entered into an agreement for the supply